Otrivine Child (Xylometazoline Hydrochloride)

Xylometazoline hydrochloride, the active ingredient in Otrivine Child, is an alpha‑adrenergic agonist presented as a nasal spray for topical use. It provides rapid relief of nasal congestion caused by colds, sinusitis, or allergic rhinitis in children. The formulation is designed for safe use in pediatric patients, delivering a measured dose to the nasal mucosa to reduce swelling of blood vessels.

GNH USA supplies Otrivine Child as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for importers.

Xylometazoline hydrochloride acts on the nasal vasculature to relieve congestion in children.

- Common cold: reduces nasal blockage and improves breathing. - Acute sinusitis: alleviates nasal swelling and facilitates drainage. - Allergic rhinitis: diminishes nasal congestion associated with allergen exposure.

Xylometazoline nasal spray may cause local and, rarely, systemic adverse reactions.

Common Side Effects: - Nasal irritation: mild burning or stinging sensation. - Dryness: reduced moisture in the nasal passages. - Sneezing: transient increase in sneezing episodes. - Headache: mild tension‑type headache. - Bitter taste: unpleasant after‑taste following administration. - Nasal discharge: watery or clear secretions.

Serious or Rare Side Effects: - Epistaxis: nosebleeds that may require medical attention. - Hypertension: elevated blood pressure in susceptible individuals. - Tachycardia: rapid heart rate. - Rebound congestion: worsening nasal blockage after prolonged use. - Severe allergic reaction: rash, swelling, or anaphylaxis. - Nasal ulceration: erosion of nasal mucosa.

When using Otrivine Child, observe the following safety measures. - Age limitation: use only in children aged 2 years and older as directed by a healthcare professional. - Duration of therapy: limit use to no more than 3‑5 consecutive days to prevent rebound congestion. - Cardiovascular caution: avoid in children with uncontrolled hypertension or severe heart disease. - Drug combination caution: do not combine with other topical nasal decongestants or systemic sympathomimetics without medical advice. - Allergy check: discontinue if signs of hypersensitivity such as rash, swelling, or difficulty breathing appear. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Xylometazoline may interact with other medicines; consider the following.

Major Interactions (Avoid): - Other nasal decongestants: concurrent use can increase systemic adrenergic effects. - Monoamine oxidase inhibitors (MAOIs): may potentiate hypertensive reactions. - Antihypertensive agents: can diminish blood‑pressure‑lowering effects.

Moderate Interactions (Monitor Closely): - Oral decongestants (e.g., pseudoephedrine): additive sympathomimetic activity. - Tricyclic antidepressants: may enhance vasoconstrictive response. - Beta‑blockers: possible alteration of heart‑rate response.